FDA preps for a new and flexible approach to genome editing in animals

FDA preps for a new and flexible approach to genome editing in animals

Source: 
Endpoints
snippet: 

With the use of CRISPR proliferating and gene drives on the horizon in the US, the FDA said that it’s now looking at a risk-based approach to regulating the gene editing of animals.